Serum, plasma, and lymphocytes from aspartyiglycosaminuria (AGU) patients and carriers and from normal controls were incubated with a fluorescent glycosylasparaginase substrate, L-aspartic acid -(7-amido-4-methylcoumarin), and the release of 7-amino-4-methylcoumarin was measured fluorometrically after incubation for 1-4 h. The mean glycosylasparaginase (EC 3.5.1.26) actMty in normal serum, plasma, and lymphocytes was 20. AspAMC, L-aspartic acid fl-(7-amido-4-methylcoumarin);
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;400. Glycosytasparaginase activity (mUlL) in serum (S) and plasma (P) of normal controls (n = 24), carners (n = 29), and AGU patients (n = 10), as wellas in isolated lymphocytes (Ly) (mU/g protein) of normal controls (n = 17), carrIers (n = 21), and AGU patients (n = 7 Fig. 1 . The mean enzyme activity was 20.2 mU/L (SD 5.0; range 10.6-28.2, n = 24) in normal serum and 0.7 mU/L (SD 0.4; range 0.0-1.2, n = 10) in AGU serum (Fig. 1A) . The corresponding plasma values (Fig. 1B) (Fig. 1, A and B) . (Fig. 1C) . (Fig. 2B) 
Results and DIscussIon
